Nihon Kohden America, LLC

Nihon Kohden America, LLC, a foreign-owned medical device manufacturer based in Irvine, California, sells respiratory care equipment, patient monitoring systems, electroencephalography (EEG) and polysomnography (sleep diagnostic) devices, and related maintenance and software services to the federal government as a prime contractor across 859 awards with no subcontracting activity. The company competes exclusively in full-and-open procurements with no SBA set-aside designations.

Nihon Kohden America's concrete capability footprint centers on branded medical devices and systems supplied directly to federal healthcare agencies. Representative work includes a $1.473 million purchase order from the Indian Health Service for a Chinle Patient Monitoring System (December 2022), a $885.873 million electroencephalograph system for the Defense Health Agency (June 2025), and a $772.727 million order from the Department of Veterans Affairs Veterans Integrated Service Network 23 for fifty-one NKV-330 ventilators with trolleys and accessories across multiple VA medical centers (July 2024). Across recent years, the company has delivered ventilator systems (NKV-330, NKV-440 variants), sleep study equipment (Polysmith systems, Nomad Air home sleep apnea testing devices), EEG systems (Neurofax EEG-1200, VitalEEG), polysomnography amplifiers (PSG-1100), telemetry systems, bedside patient monitors, and associated software, maintenance services, training, and installation support. Many awards are marked as sole-source or brand-name-only procurements, reflecting Nihon Kohden's established installed base at federal medical facilities.

Customer concentration is fragmented but anchored in Veterans Health Administration networks and civilian federal health services. The top five customers by award count account for 27% of awards, with the Indian Health Service leading at 86 awards ($8.8 million combined potential value), followed by the Department of the Navy Bureau of Medicine and Surgery (43 awards, $1.4 million), VA Veterans Integrated Service Network 22 (40 awards, $6.6 million), VA Veterans Integrated Service Network 17 (30 awards, $6.4 million), and the Defense Health Agency (30 awards, $5.9 million). The top five customers by potential value reveal a different concentration: VA VISN 12 anchors the dollars at 22 awards valued at $28.4 million combined, followed by Indian Health Service, VA VISN 22, VA VISN 17, and the Defense Health Agency. The Indian Health Service places the most individual orders but carries lower average order values; VA VISN 12 concentrates larger procurements. Across the portfolio, 44 distinct customer agencies are served, indicating widespread federal health-system penetration.

Nihon Kohden America holds position on two named parent vehicles. A $450 million multiple-award Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency Troop Support Medical Supply Chain (awarded January 13, 2022, through January 12, 2032) covers a broad range of medical capital equipment and related services including patient monitoring systems, anesthesia equipment, infant care devices, and critical care equipment; the company is using this vehicle to support Department of Defense and other federal agency procurements. Additionally, the company maintains a single-award IDIQ with VA Veterans Integrated Service Network 17 for telemetry system upgrades (awarded April 1, 2026, through March 31, 2028, with a $275 thousand ceiling). The company also places task orders under two Federal Supply Schedules: Schedule V797P4143A (195 task orders, $11.7 million combined potential value) and Schedule V797P3143K (24 task orders, $30 thousand combined potential value). A broader contract vehicle category labeled "Medical Equipment and Supplies" accounts for 205 task orders ($24 million combined potential value), representing blanket purchase agreements and schedule-based ordering from multiple federal agencies.

Activity has accelerated in 2025 with 37 awards, up from 24 in 2022 and 16 in 2024, indicating growth in federal medical device procurement or market expansion. Thirteen awards (combined potential value $1.5 million) reach ultimate completion within the next twenty-four months, representing a modest recompete window. The source does not indicate any sub-award footprint; all 859 awards are prime contractor awards. Nihon Kohden America does not sub-contract; it performs as an original equipment manufacturer and sole supplier of its branded product lines.

The company's product portfolio maps to electromedical apparatus manufacturing (314 awards under NAICS 334510) and surgical and medical instrument manufacturing (253 awards under NAICS 339112 and related codes). Most work is classified under PSC Medical and Surgical Instruments, Equipment, and Supplies (608 awards), with maintenance, repair, and rebuild services (44 awards) and imaging equipment (27 awards) rounding out secondary work. Obligated dollars are $63.1 million against $546.3 million combined potential value, reflecting many awards still in performance or with future option periods. Nihon Kohden America is a subsidiary of Japanese parent Nihon Kohden Corporation and maintains steady federal healthcare market presence through direct equipment sales and contracted support services, predominantly to VA networks and Indian Health Service installations.